Latest filing published 26 Oct 2026 for Lite Strategy, Inc., €5,580.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Nicholas Glover: trading record in brief
This profile gathers the share dealings of Nicholas Glover across 2 companies, led by Lite Strategy, Inc. and Sierra Oncology, Inc. The record holds 4 filings, for trades running from 15 January 2016 to 23 July 2025.
Both buying and selling appear: 2 purchases worth €11k, against 1 sale worth €46k. On balance, insiders were net sellers of €36k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 option exercise. In 2026 alone, the filings show 2 purchases and no sales.
The record was last updated on 26 October 2026 with an open-market purchase (€5,580) in Lite Strategy, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nicholas Glover
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$6.55Common StockSEC:0001193125-26-432220:0Canonical exit: 20 Oct 2025 (T+90)
- 1,000 shares@ US$6.00Common StockSEC:0001193125-26-432220:1Canonical exit: 21 Oct 2025 (T+90)
- 5,000 sharesCommon StockSEC:0001209191-16-092226:0
- 5,000 shares@ US$10.0446100.0% of flowCommon StockSEC:0001209191-16-092226:1
4 of 4 declarations
